Scarica l'app Stockscreener
0.36
0.50%
-0.0018
Precedente Chiudi:
$0.3618
Aprire:
$0.3601
Volume 24 ore:
72,367
Relative Volume:
0.20
Capitalizzazione di mercato:
$8.33M
Reddito:
$81.89M
Utile/perdita netta:
$-55.20M
Rapporto P/E:
-0.1335
EPS:
-2.6959
Flusso di cassa netto:
$-67.40M
1 W Prestazione:
-0.55%
1M Prestazione:
-5.19%
6M Prestazione:
-21.74%
1 anno Prestazione:
-85.66%
Intervallo 1D:
$0.3526
$0.363
Intervallo di 1 settimana:
$0.3526
$0.3688
Portata 52W:
$0.29
$2.59
Turnstone Biologics Corp Stock (TSBX) Company Profile
Nome
Turnstone Biologics Corp
Settore
Industria
Telefono
347-897-5988
Indirizzo
9310 ATHENA CIRCLE, SUITE 300, LA JOLLA
Confronta TSBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TSBX
Turnstone Biologics Corp
|
0.36 | 8.37M | 81.89M | -55.20M | -67.40M | -2.6959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Turnstone Biologics Corp Stock (TSBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-05 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-10-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-08-16 | Iniziato | SVB Securities | Market Perform |
| 2023-08-15 | Iniziato | BofA Securities | Buy |
| 2023-08-15 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Turnstone Biologics Corp Borsa (TSBX) Ultime notizie
What analysts say about Turnstone Biologics Corp. stockRapidly expanding wealth - PrintWeekIndia
Is Turnstone Biologics Corp. a good long term investmentFree Investment Risk Control - PrintWeekIndia
What drives Turnstone Biologics Corp. stock priceFree Stock Market Knowledge Sharing - Autocar Professional
What analysts say about Turnstone Biologics Corp. stock outlookDouble or triple returns - jammulinksnews.com
Why Turnstone Biologics Corp. stock attracts strong analyst attentionTop Gaining Low Risk Assets - Newser
Turnstone Biologics Corp. Stock Analysis and ForecastRapid growth opportunities - jammulinksnews.com
What makes Turnstone Biologics Corp. stock price move sharplyVerified Chart Patterns - Newser
How Turnstone Biologics Corp. stock performs during market volatilityLow Risk Trade Timing Signals - Newser
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - The Malaysian Reserve
How did TSBX's revenue and expenses trend in Q4 2024? - AInvest
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Turnstone Biologics Corp. (NASDAQ: TSBX) - TradingView
Turnstone Biologics To Merge With Biotech Royalty Aggregator XOMA, But Retail Sentiment Slumps - MSN
XOMA stock rises after acquisition of Turnstone Biologics By Investing.com - Investing.com India
Millennium Management LLC Cuts Position in Turnstone Biologics Corp. (NASDAQ:TSBX) - Defense World
Atara Biotherapeutics (NASDAQ:ATRA) & Turnstone Biologics (NASDAQ:TSBX) Financial Analysis - Defense World
Check out Turnstone Biologics Corp's stock price (TSBX) in real time - CNBC
Turnstone Biologics Reports Q1 Loss Amid Strategic Shift - TipRanks
Turnstone Biologics Corp Azioni (TSBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):